OPTIMIZED STRAIN OF POLIOVIRUS TYPE 3 FOR THERAPY OF SOLID TUMOURS
2023-12-29
专利权人ENGELHARDT INST MOLECULAR BIOLOGY (ENGE-Non-standard) ; FEDERAL STATE BUDGETARY INST (FSBI-C)
申请日期2023-12-29
专利号RU2836222-C1
成果简介NOVELTY - Described is a method for optimizing Sabin type 3 poliovirus vaccine for selective destruction of tumour cells, involving: culturing Sabin type 3 poliovirus vaccine on a mixture of glioblastoma tumour cells, wherein replication is initiated in the HEK293T cell culture, 24 hours after infection, the cells are washed and incubated for 48 hours, after which the virus is isolated from the culture; virus passaging for six months in a mixed culture of glioblastoma cells with determination of virus titre and analysis of its cytopathic properties; modification of internal ribosome binding site (IRES), by amplification of IRES using primers SEQ ID NO: 1 and SEQ ID NO: 2, amplification of a DNA fragment coding a genome of a plasmid backbone using primers SEQ ID NO: 3 and SEQ ID NO: 4, with subsequent creation of circular plasmid, which is induced by virus. Invention enables to obtain a highly oncolytic recombinant poliovirus which effectively lyses solid tumours of various histological affiliations. Strain obtained using the disclosed method has shown its effectiveness and safety in experiments in vitro on models of tumour and conditionally normal cell cultures. USE - Biotechnology. ADVANTAGE - Optimized recombinant strain has shown high oncolytic activity on various models in vivo in immunodeficient mice with xenografts of human tumours and humanized model of orthotopic rat C6 glioma. 2 cl, 4 dwg, 6 ex
IPC 分类号C12N-005/10
国家俄罗斯
专业领域生物科学
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/18594
专题中国科学院新疆生态与地理研究所
作者单位
1.ENGELHARDT INST MOLECULAR BIOLOGY (ENGE-Non-standard)
2.FEDERAL STATE BUDGETARY INST (FSBI-C)
推荐引用方式
GB/T 7714
LIPATOVA A V,VOROBEV P O,KUPRASH D V,et al. OPTIMIZED STRAIN OF POLIOVIRUS TYPE 3 FOR THERAPY OF SOLID TUMOURS. RU2836222-C1[P]. 2023.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。